Companies/EU/NRO

NEURONES

Last · —$36.45+0.70 (+1.96%)live · yahoo · 20m ago
Vol 1.0K ≈ 37.6K
Market cap——
P/E · TTM16.0fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameNEURONES
HQEurope (EU)
ListingEU NRO
ISINFR0004050250
LEI9695008Y07TSG8SZCG57
SectorTechnology
IndustryIT Services & Consulting
CurrencyEUR
Entity registrylei:9695008Y07TSG8SZCG57
Websitewww.neurones.net
LinkedIn
Employees7,099
AddressNeurones SA Immeuble Le Clemenceau 1 92024, Nanterre +33 1 41 37 41 37
Headline financial metrics
Revenue€857.2M
Operating income€75.6M
Net income€52.1M
Free cash flow€50.1M
Operating margin8.8%
Net margin6.1%
Return on equity13.0%
Period2025
Loading chart…

Press & signals

3 of 4 recent
  • GlobeNewswire

    NEURONES: 6.9% net profit in 1st half 2026

  • GlobeNewswire

    NEURONES: Organic growth up 8% in 2nd quarter 2026

  • GlobeNewswire

    NEURONES: Declaration of transactions on treasury shares (June 22 to 26, 2026)

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
8-KNEURONES: 6.9% net profit in 1st half 2026
2026-09-092026-09-090
8-KNEURONES: Organic growth up 8% in 2nd quarter 2026
2026-08-052026-08-050
DISCLOSURENEURONES: Declaration of transactions on treasury shares (June 22 to 26, 2026)
2026-06-302026-06-300
Showing 5 of 171 filings